GGrantIndex
← Search

PHASE II PILOT STUDY OF RITUXIMAB IN THE TREATMENT OF CHRONIC LUNG TRANSPLANT

$4,090M01FY2005RRNIH

University Of Pennsylvania, Philadelphia PA

Investigators

Linked publications & trials

View original record on NIH RePORTER →